1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. STRYKER CORP.
282.55-0.05(-0.02%)
2.1M
XNYS Volume

XNYS 13 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Stryker quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Stryker share price target, revenues, EPS, net income and more

Stryker quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Stryker Jun-2026 Quarterly Revenue is $6,589 Million which is growth of 9.4% YoY.

  • POSITIVE

    Quarterly Net Profit Stryker Jun-2026 Quarterly Net Profit is $1,276 Million which is growth of 44.3% YoY.

Stryker Corp., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
6,5896,0207,1716,0576,0225,8666,4365,4945,4225,2435,8154,9094,996
Cost Of Rev.
2,0912,2102,5432,2052,1812,1222,2621,9772,0061,9102,1121,7511,815
Gross Profit
4,4983,8104,6283,8523,8413,7444,1743,5173,4163,3333,7033,1583,181
⌄
2,8382,8742,8172,6442,6732,8722,6162,4322,3652,3612,4402,2182,213
Operating Profit
1,6609361,8111,2081,1688721,5581,0851,0519721,263940968
-141-148-----------
Profit Before Tax
1,5648501,7051,0291,0167645281,0439989231,226869899
Tax
288105856170132110-1820917313583177161
⌄
1,2767458498598846545468348257881,143692738
Diluted NI Avail to Com Stockholders Ann.
1,2767458498598846545468348257881,143692738
Basic EPS
3.322.22.32.31.71.42.22.22.131.82
Diluted EPS After ExtraOrdinary
3.72.64.53.23.12.842.92.82.53.52.52.5
Number Of Shares End
383.5382.9382.5382.4382.2381.7381.3381.1381380.4379.9379.8379.7
Net Income Continuing Discontinued Operations
1,2767458498598846545468348257881,143692738
Normalized Income
1,4241,0041,7261,2331,2111,0971,5461,1071,0859621,326944976
Interest Income
-------------
Interest
141148-----------
Net Interest Income
-141-148-----------
EBIT
1,7059981,7051,0291,0167649241,0439989231,582869899
EBITDA
2,0011,2982,0211,3381,3121,0361,1881,3111,2561,1831,8321,1311,158
Reconciled Cost Of Rev.
1,9702,0902,4162,0852,0722,0172,1541,8681,9031,8032,0111,6531,717
Reconciled Depr.
296300316309296272264268258260250262259
Profit From Continuing Operations
1,2767458498598846545468348257881,143692738
Normalized EBITDA
2,0021,2982,1961,5901,5191,1791,8221,3531,3091,2321,5191,2111,230
*All financials are in USD Million and price data in USD

Stryker competitor comparison and performance snapshot within industry

Stryker annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Stryker Dec-2025 Annual Revenue is $25,116 Million which is growth of 11.2% YoY.

  • POSITIVE

    Annual Net Profit Stryker Dec-2025 Annual Net Profit is $3,246 Million which is growth of 8.5% YoY.

Stryker Corp., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
10.8%
11.8%
 25,11622,59520,49818,44917,10814,35114,88413,60112,44411,3259,946
Cost Of Rev. Ann.
9.6%
11.3%
9,0499,0518,1557,4406,8716,1405,2945,1884,6634,2713,8303,344
Gross Profit Ann.
11.5%
12.1%
16,78816,06514,44013,05811,57810,9689,0579,6968,9388,1737,4956,602
Operating Exp. Ann.
8.8%
10.1%
11,17311,0069,7749,1528,5368,2816,8176,7916,3785,7105,1714,445
Operating Profit Ann.
18.5%
17.7%
5,6155,0594,6663,9063,0422,6872,2402,9052,5602,4632,3242,157
-
-
 -607----------
Other Exp. Ann.
-
-
 62-1,174-233-359-406-286-343-204-400-403-422
PBT Ann.
18.9%
18.2%
5,1484,5143,4923,6732,6832,2811,9542,5622,3562,0631,9211,735
Tax Ann.
57.4%
29%
1,4191,268499508325287355479-1,1971,043274296
⌄
11.2%
15.2%
3,7293,2462,9933,1652,3581,9941,5992,0833,5531,0201,6471,439
Diluted NI Avail to Com Stockholders Ann.
11.2%
15.2%
3,7293,2462,9933,1652,3581,9941,5992,0833,5531,0201,6471,439
EPS Ann.
11.1%
14.6%
 8.57.98.36.25.34.35.69.52.74.43.8
Diluted EPS Ann.
10.7%
14.9%
 8.47.88.36.25.24.25.59.32.74.43.8
Number Of Shares End
0.4%
0.3%
 382.5381.3379.9378.5377.6376.1374.6374.4374.6374.7374.2
Total Exp. Ann.
9.2%
10.6%
 20,05717,92916,59215,40714,42112,11111,97911,0419,9819,0017,789
Net Income Continuing Discontinued Operations Ann.
11.2%
15.2%
3,7293,2462,9933,1652,3581,9941,5992,0833,5531,0201,6471,439
Normalized Income Ann.
13.8%
13.3%
5,3875,2674,7004,0663,5713,4742,8273,1392,7792,4652,1941,949
Interest Income Ann.
-
-
 -----------
Interest Ann.
-
-
 607----------
EBITDA Ann.
16.3%
15.4%
6,6586,3144,9385,0574,0183,6083,0813,6273,3432,9522,6952,240
Reconciled Cost Of Rev. Ann.
9.7%
11.6%
8,5618,5907,7287,0476,5005,7694,9544,8744,3574,0003,6033,157
Reconciled Depr. Ann.
6.1%
8%
1,2211,1931,0501,028998990812778723642546397
Profit From Continuing Operations Ann.
11.2%
15.2%
3,7293,2462,9933,1652,3581,9941,5992,0833,5531,0201,6471,439
Normalized EBITDA Ann.
15.2%
16.1%
7,0866,4846,6934,9524,2413,7803,0693,8753,3063,2783,0282,850
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
11.2%
2Y CAGR
10.7%
3Y CAGR
10.8%
5Y CAGR
11.8%
7Y CAGR
9.2%
10Y CAGR
9.7%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
8.5%
2Y CAGR
1.3%
3Y CAGR
11.2%
5Y CAGR
15.2%
7Y CAGR
-1.3%
10Y CAGR
8.5%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
12.6%
2Y CAGR
9.7%
3Y CAGR
8.8%
5Y CAGR
10.1%
7Y CAGR
8.1%
10Y CAGR
9.5%
Operating Expenses Annual Cr growth is higher than historical averages.

Stryker balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Stryker Dec-2025 Total Shareholders Fund is $22,420 Million which is growth of 8.7% YoY.

  • POSITIVE

    Total Assets Stryker Dec-2025 Total Assets is $47,844 Million which is growth of 11.3% YoY.

Stryker Corp., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
9.1%
6.9%
47,84442,97139,91236,88434,63134,33030,16727,22922,19720,43516,247
⌄
7.8%
3.7%
25,42422,33721,31920,26819,75421,24617,36015,49912,21710,8857,736
⌄
10.5%
11.4%
22,42020,63418,59316,61614,87713,08412,80711,7309,9669,5508,511
Total Capitalization Ann.
9.4%
7.2%
37,27932,82229,49428,47327,34926,31423,03820,21616,55616,23611,764
Tangible Assets Ann.
-
-
-2,552384-1,243-3,149-2,881-5,248-489-996-679-3142,581
Working Capital Ann.
20.6%
8.3%
6,9617,2314,5973,9725,4684,6666,9604,9264,5084,7134,441
Invested Capital Ann.
8.9%
7.2%
38,27934,23131,58829,66427,35627,07523,89721,58917,18816,46412,533
Tangible Book Value Ann.
-
-
-2,552384-1,243-3,149-2,881-5,248-489-996-679-3142,581
Borrowings Ann.
6.7%
2.5%
15,85913,59712,99513,04812,47913,99111,0909,8597,2226,9144,022
Net Debt Ann.
1.9%
1.4%
11,8489,94510,02411,2049,53511,0486,7536,2434,6803,598643
Share Issued Ann.
0.3%
0.3%
382.5381.4380.1378.7377.5376.1374.5374.4374.4375373
Number Of Shares End
0.4%
0.3%
382.5381.3379.9378.5377.6376.1374.6374.4374.6374.7374.2
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
11.3%
2Y CAGR
9.5%
3Y CAGR
9.1%
5Y CAGR
6.9%
7Y CAGR
8.4%
10Y CAGR
11.4%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
2.3%
2Y CAGR
-0.8%
3Y CAGR
7.3%
5Y CAGR
9.1%
7Y CAGR
7.1%
10Y CAGR
8.3%
Total Current Liabilities Annual Cr growth is lower than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
8.7%
2Y CAGR
9.8%
3Y CAGR
10.5%
5Y CAGR
11.4%
7Y CAGR
9.7%
10Y CAGR
10.2%
Total ShareHolders Funds Annual growth is lower than historical averages.

Stryker ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Stryker Book Value Per Share is $59 which is growth of 8.3% YoY.

  • NEUTRAL

    ROE Stryker ROE is 0% which is growth of 0% YoY.

Stryker Corp., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-7.22%8.24%6.59%5.78%4.96%7.26%14.38%4.79%8.98%8.47%
ROE Ann. %
-
-
-15.26%17.98%14.97%14.26%12.35%16.98%32.75%10.45%18.24%16.82%
ROIC %
-
-
-1.63.71.92.42.13.310.7-1.43.14.3
OPM Ann. %
6.9%
5.2%
20.14%20.65%19.06%16.49%15.71%15.61%19.52%18.82%19.79%20.52%21.69%
Inventory Turnover Ratio Ann.
-
-
-1.71.71.91.81.61.71.71.92.12.1
Asset Turnover Ann. %
-
-
-0.60.50.50.50.50.50.60.60.60.6
Working Capital Turnover Ann.
-7.8%
3%
3.63.14.54.63.13.12.12.82.82.42.2
Quick Ratio Ann.
-
-
-1.10.90.91.31.11.71.31.41.71.6
Current Ratio Ann.
-
-
-21.61.62.21.92.622.32.52.3
Interest Coverage Ratio Ann.
-
-
-----------
LT Debt To Equity Ann.
-
-
-0.60.60.70.810.80.70.70.70.4
*All financials are in USD Million and price data in USD

Stryker cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Stryker Dec-2025 Cash From Operating Activity is $5,044 Million which is growth of 18.9% YoY.

  • NEGATIVE

    Net Cash Flow Stryker Dec-2025 Net Cash Flow is $291 Million which is growth of -59.4% YoY.

Stryker Corp., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
24.3%
9%
5,0444,2423,7112,6243,2633,2772,1912,6101,5591,812899
-
-
-4,866-3,000-962-2,924-859-4,701-1,455-2,857-1,613-4,1911,956
-
-
113-525-1,594-749-2,365-1131,329-7942,361-1,141
Cash Plus Cash Eqv. End Of Year Ann.
29.6%
6.4%
4,0113,6522,9711,8442,9442,9434,3373,6162,5423,3163,379
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
2917171,155-1,04939-1,4357391,082-848-181,714
Cash Plus Cash Eqv. Begin Of Year Ann.
7.4%
-3.4%
3,6522,9711,8442,9442,9434,3373,6162,5423,3163,3791,795
Income Tax Paid Supplemental Data Ann.
25.7%
25.4%
1,002989693505622323457539312510497
Interest Paid Supplemental Data Ann.
21.6%
13.9%
582396356324325304286248264180101
Capex Ann.
-
-
-761-755-575-588-525-487-649-572-598-490-270
Issuance Of Capital Stock Ann.
-
-
-----------
Issuance Of Debt Ann.
25.7%
-2%
2,9793,0111,2411,50053,2922,6423,1261,2324,5472,320
Repayment Of Debt Ann.
-
-
-1,400-2,039-2,058-653-1,151-2,297-1,342-669-933-1,635-2,272
Repurchase Of Capital Stock Ann.
-
-
-----307-300-230-13-700
Free Cash Flow Ann.
28.1%
9%
4,2833,4873,1362,0362,7382,7901,5422,0389611,322629
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
18.9%
2Y CAGR
16.6%
3Y CAGR
24.3%
5Y CAGR
9%
7Y CAGR
9.9%
10Y CAGR
18.8%
Cash from Operating Activity Annual growth is stable compared to historical averages.
Cash from Financing Act. Ann.
7Y CAGR
-29.7%
Cash from Financing Annual Activity growth is stable compared to historical averages.